First-pass extracted concept

LTβR agonism

Candidate: concept label1 source documents3 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

LTβR agonism has been shown to promote TLS formation and immune activation.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2026MEDDOI PubMed

1 evidence snippet 3 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1combination strategysupports2026Source 1DOI PubMed

Selective LTβR modulation may synergize with immune checkpoint blockade and CAR T cell therapies to overcome immunotherapy resistance in refractory solid tumors.

Claim 2preclinical effectsupports2026Source 1DOI PubMed

In preclinical colorectal and cervical cancer models, LTβR activation induces tertiary lymphoid structures, high endothelial venules, and immune infiltration, improving responsiveness to immune checkpoint blockade.

Claim 3therapeutic strategysupports2026Source 1DOI PubMed

LTβR agonism promotes TLS formation and immune activation.